Previous 10 | Next 10 |
Through the agreement, CCI will support Softhread’s entrance into the rapidly evolving Health Care 4.0 ecosystem for health care delivery Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants Inte...
Greater Toronto Area Company Improving Healthcare Delivery and Treatments Novo Integrated Sciences, Inc., a NASDAQ listed company operating in the GTA (“Novo”), is pioneering the delivery of non-catastrophic healthcare in both Canada and the U.S. through the in...
Novo Integrated Sciences press release ( NASDAQ: NVOS ): FQ3 GAAP EPS of -$0.13. Revenue of $13.85M (+481.9% Y/Y). Cash and cash equivalents were $12.6M, total assets were $71.7M, total liabilities were $27.3M, and stockholders’ equity was $44.4M. For furt...
Revenue Increased 382% Sequentially and 481% Year-to-Year for the Fiscal 2022 Third Quarter Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a ...
Histogen ( HSTO ) +78% . Canoo ( GOEV ) +74% after signing a deal with Walmart for 4,500 all electric delivery vehicles. Novo Integrated Sciences ( NVOS ) +14% expects to report over fivefold increase in Q3 revenue. Annexon ( ANNX ) +13% p...
Novo Integrated Sciences ( NASDAQ: NVOS ) said Monday it expects to report Q3 revenue of $13.4M-$13.9M, up ~367-384% sequentially and up ~463-484% Y/Y. The strong performance was driven by an increase in proprietary and outsourced product sales. NVOS expects to report ...
Management expects over 365% Revenue Growth Sequentially for the Fiscal 2022 Third Quarter Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a m...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product...
Novo Integrated Sciences press release (NASDAQ:NVOS): FQ2 GAAP EPS of -$0.17. Revenue of $2.87M (+38.0% Y/Y). For further details see: Novo Integrated Sciences GAAP EPS of -$0.17, revenue of $2.87M
Management expects Triple-digit Percentage Revenue Growth sequentially for the Fiscal 2022 Third Quarter Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness th...
News, Short Squeeze, Breakout and More Instantly...
Novo Integrated Sciences Inc. Company Name:
NVOS Stock Symbol:
OTCMKTS Market:
Novo Integrated Sciences Inc. Website:
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received notice of the commencement of disbursement for the complete monetization of a Standby Letter of Credit (“SBLC”). The initial disbursement represen...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...